AAAAAA
Results: 51-75/116
Authors:
MALMSTROM PU
RINTALA E
WAHLQVIST R
HELLSTROM P
HELLSTEN S
HANNISDAL E
ALFTHAN O
RUSK J
OPAS MA
JAUHIAINEN K
OTTELIN J
PERMI J
SALMELA H
TAINIO H
TALJA M
TUHKANEN K
VIITANEN J
BREVIK B
HOEG OM
JOHANNESSEN NB
FARSUND T
MEDBY PC
MURI O
FOSSA SD
OUS S
SANDER S
TVETER KJ
OMLAND H
STEINSVIK E
URNES T
WAALER G
OGREID P
OSTREM T
ANDERSSON L
EDSMYR F
EKMAN P
GUSTAFSON H
NORMING U
WIJKSTROM H
KARLBERG L
KIHL B
LINDEBORG T
Citation: Pu. Malmstrom et al., 5-YEAR FOLLOW-UP OF A PROSPECTIVE TRIAL OF RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY - NORDIC CYSTECTOMY TRIAL-I, The Journal of urology, 155(6), 1996, pp. 1903-1906
Authors:
BRAENDENGEN M
WINDEREN M
FOSSA SD
Citation: M. Braendengen et al., CLINICAL-SIGNIFICANCE OF ROUTINE PRE-CYSTECTOMY BONE SCANS IN PATIENTS WITH MUSCLE-INVASIVE BLADDER-CANCER, British Journal of Urology, 77(1), 1996, pp. 36-40
Authors:
STEYERBERG EW
KEIZER HJ
FOSSA SD
SLEIJFER DT
BAJORIN DF
DONOHUE JP
HABBEMA JDF
Citation: Ew. Steyerberg et al., RESECTION OF RESIDUAL RETROPERITONEAL MASSES IN TESTICULAR CANCER - EVALUATION AND IMPROVEMENT OF SELECTION CRITERIA, British Journal of Cancer, 74(9), 1996, pp. 1492-1498
Authors:
FOSSA SD
STERNBERG C
SCHER HI
THEODORE CH
MEAD B
DEARNALEY D
ROBERTS JT
SKOVLUND E
Citation: Sd. Fossa et al., SURVIVAL OF PATIENTS WITH ADVANCED UROTHELIAL CANCER TREATED WITH CISPLATIN-BASED CHEMOTHERAPY, British Journal of Cancer, 74(10), 1996, pp. 1655-1659
Authors:
HEIMDAL K
OLSSON H
TRETLI S
FLODGREN P
BORRESEN AL
FOSSA SD
Citation: K. Heimdal et al., FAMILIAL TESTICULAR CANCER IN NORWAY AND SOUTHERN SWEDEN, British Journal of Cancer, 73(7), 1996, pp. 964-969
Authors:
HEIMDAL K
OLSSON H
TRETLI S
FLODGREN P
BORRESEN AL
FOSSA SD
Citation: K. Heimdal et al., RISK OF CANCER IN RELATIVES OF TESTICULAR CANCER-PATIENTS, British Journal of Cancer, 73(7), 1996, pp. 970-973
Authors:
HEIMDAL K
ANDERSEN TI
SKREDE M
FOSSA SD
BERG K
BORRESEN AL
Citation: K. Heimdal et al., ASSOCIATION STUDIES OF ESTROGEN-RECEPTOR POLYMORPHISMS IN A NORWEGIANTESTICULAR CANCER POPULATION, Cancer epidemiology, biomarkers & prevention, 4(2), 1995, pp. 123-126
Authors:
FOSSA SD
HORWICH A
RUSSEL JM
ROBERTS JP
JAKES R
Citation: Sd. Fossa et al., OPTIMAL FIELD SIZE IN ADJUVANT TREATMENT OF STAGE-I SEMINOMA, European journal of cancer, 31A, 1995, pp. 902-902
Authors:
DUELAND S
STENWIG AE
HEILO A
FOSSA SD
Citation: S. Dueland et al., TREATMENT AND OUTCOME OF PATIENTS WITH EXTRAGONADAL GERM-CELL TUMORS, European journal of cancer, 31A, 1995, pp. 911-911
Authors:
HOLLENDER A
STENWIG EA
OUS S
AASS N
FOSSA SD
Citation: A. Hollender et al., SURVIVAL IN PATIENTS WITH MALIGNANT GERM-CELL TUMOR PERSISTENT AFTER CISPLATIN-BASED INDUCTION CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 912-912
Authors:
JACOBSEN KD
FOSSA SD
AAS N
OLSEN DR
Citation: Kd. Jacobsen et al., TESTICULAR DOSE AND FUNCTION AFTER PARAAORTIC STRIP AND DOG-LEG FIELDRADIOTHERAPY FOR SEMINOMA STAGE-I, European journal of cancer, 31A, 1995, pp. 913-913
Authors:
RAABE NK
FOSSA SD
Citation: Nk. Raabe et Sd. Fossa, TUMOR-SPECIFIC SURVIVAL IN RADICALLY OPERATED PATIENTS WITH INVASIVE BREAST-CARCINOMA, European journal of cancer, 31A, 1995, pp. 1042-1042
Authors:
WANDERAS EH
TRETLI S
FOSSA SD
Citation: Eh. Wanderas et al., TRENDS IN INCIDENCE OF TESTICULAR CANCER IN NORWAY 1955-1992, European journal of cancer, 31A(12), 1995, pp. 2044-2048
Authors:
BRAUSI M
JONES WG
FOSSA SD
DEMULDER PHM
DROZ JP
LENTZ MA
VANGLABBEKE M
PAWINSKI A
Citation: M. Brausi et al., HIGH-DOSE EPIRUBICIN IS EFFECTIVE IN MEASURABLE METASTATIC PROSTATE-CANCER - A PHASE-II STUDY OF THE EORTC GENITOURINARY GROUP, European journal of cancer, 31A(10), 1995, pp. 1622-1626
Authors:
STEYERBERG EW
KEIZER HJ
FOSSA SD
SLEIJFER DT
TONER GC
KOOPS HS
MULDERS PFA
MESSEMER JE
NEY K
DONOHUE JP
BAJORIN D
STOTER G
BOSL GJ
HABBEMA JDF
Citation: Ew. Steyerberg et al., PREDICTION OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - MULTIVARIATE-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 6 STUDY-GROUPS, Journal of clinical oncology, 13(5), 1995, pp. 1177-1187
Authors:
HJERMSTAD MJ
FOSSA SD
BJORDAL K
KAASA S
Citation: Mj. Hjermstad et al., TEST-RETEST STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER CORE QUALITY-OF-LIFE QUESTIONNAIRE, Journal of clinical oncology, 13(5), 1995, pp. 1249-1254
Authors:
FOSSA SD
AAMDAL S
NAUME B
GALLATI H
Citation: Sd. Fossa et al., SERUM LEVELS OF CYTOKINES AND SOLUBLE CYTOKINE RECEPTORS IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA OR MALIGNANT-MELANOMA RECEIVING IL-2 INTERFERON-ALPHA COMBINATION THERAPY, Acta oncologica, 34(5), 1995, pp. 599-603
Authors:
FOSSA SD
LEHNE G
HEIMDAL K
THEODORSEN L
Citation: Sd. Fossa et al., CLINICAL AND BIOCHEMICAL LONG-TERM TOXICITY AFTER POSTOPERATIVE CISPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH LOW-STAGE TESTICULAR CANCER, Oncology, 52(4), 1995, pp. 300-305
Authors:
LOTHE RA
PELTOMAKI P
TOMMERUP N
FOSSA SD
STENWIG AE
BORRESEN AL
NESLAND JM
Citation: Ra. Lothe et al., MOLECULAR-GENETIC CHANGES IN HUMAN MALE GERM-CELL TUMORS, Laboratory investigation, 73(5), 1995, pp. 606-614
Authors:
DAVIDSON PJT
HOP W
KURTH KH
FOSSA SD
WAEHRE H
SCHRODER FH
Citation: Pjt. Davidson et al., PROGRESSION IN UNTREATED CARCINOMA OF THE PROSTATE METASTATIC TO REGIONAL LYMPH-NODES (STAGE T0 4,N1 TO 3,M0,D1), The Journal of urology, 154(6), 1995, pp. 2118-2122
Authors:
BERNER A
GEITVIK G
KARLSEN F
FOSSA SD
NESLAND JM
BORRESEN AL
Citation: A. Berner et al., TP53 MUTATIONS IN PROSTATIC-CANCER - ANALYSIS OF PRETREATMENT AND POSTTREATMENT ARCHIVAL FORMALIN-FIXED TUMOR-TISSUE, Journal of pathology, 176(3), 1995, pp. 299-308
Authors:
OTNES B
HARVEI S
FOSSA SD
Citation: B. Otnes et al., THE BURDEN OF PROSTATE-CANCER FROM DIAGNOSIS UNTIL DEATH, British Journal of Urology, 76(5), 1995, pp. 587-594
Authors:
JOSEFSEN D
WAEHRE H
PAUS E
FOSSA SD
Citation: D. Josefsen et al., INCREASE OF SERUM PROSTATIC SPECIFIC ANTIGEN AND CLINICAL PROGRESSIONIN PN-CANCER(MO PROSTATE), British Journal of Urology, 75(4), 1995, pp. 502-506
Authors:
BERNER A
WAERE H
NESLAND JM
PAUS E
DANIELSEN HE
FOSSA SD
Citation: A. Berner et al., DNA-PLOIDY, SERUM PROSTATE-SPECIFIC ANTIGEN, HISTOLOGICAL GRADE AND IMMUNOHISTOCHEMISTRY AS PREDICTIVE PARAMETERS OF LYMPH-NODE METASTASES IN T1-T3 MO PROSTATIC ADENOCARCINOMA/, British Journal of Urology, 75(1), 1995, pp. 26-32
Authors:
FOSSA SD
DROZ JP
STOTER G
KAYE SB
VERMEYLEN K
SYLVESTER R
Citation: Sd. Fossa et al., CISPLATIN, VINCRISTINE AND IFOSPHAMIDE COMBINATION CHEMOTHERAPY OF METASTATIC SEMINOMA - RESULTS OF EORTC TRIAL-30874, British Journal of Cancer, 71(3), 1995, pp. 619-624